Xiaflex is once again on our radar as the Phase IIb results are out.
It has to be said that the results to me do not seem to be impressive. Using a needle on the penis of a peyronie's patient no doubt holds some risk in its own right, so I feel that the results would have to be more impressive to get me to consider Xiaflex as a valid treatment option.
Of course it may well be that in conjunction with other treatments, such as trental, the effectiveness of Xiaflex is more apparent. It may also be the case that in the time before approval (possibly 2012) skilled doctors will learn to better use Xiaflex injections to reduce curvature. There will possibly be opportunities for some to try the treatment before 2012, due to its success in treating Dupuytren's Contracture, but if these results are anything to go by, I can't say that I'm eager to be at the front of the queue.